引導式測驗 · 中等 等級
FDA 預先確定的人工智慧裝置變更控制計畫測驗
了解 PCCP 的三個要素、FDA 審查、授權變更邊界,以及為什麼計劃不全面許可模型更新。
問題 1 的 8
Which three elements form the core of an AI-device PCCP?
預覽每個問題8 問題
當您參加測驗時,就會出現答案和解釋。
- Which three elements form the core of an AI-device PCCP?
- Marketing plan, staffing chart, and sales forecast
- Planned modifications, modification protocol, and impact assessment
- Training manual, warranty, and cybersecurity certificate
- Clinical protocol, patent list, and reimbursement plan
- When does FDA review a proposed PCCP?
- As part of a medical-device marketing submission
- Only after the manufacturer releases every update
- Only during an annual inspection
- When patients request one
- What does PCCP authorization allow a manufacturer to do?
- Change the device’s intended use without review
- Skip all quality-system duties
- Implement changes within the authorized plan without a separate submission for each described change
- Replace all post-market monitoring
- A manufacturer wants to add a new patient population that its PCCP did not describe. What is the appropriate next step?
- Release the change if the model score improves
- Treat the change as automatically covered
- Delete the old validation record
- Assess the change separately for any required new marketing submission
- Which version of FDA’s AI-device PCCP guidance is final?
- August 2025 final guidance
- A 2019 draft rule
- A 2023 statute
- A 2024 voluntary industry code
- What should a modification protocol specify?
- Only the release date
- How changes will be developed, validated, and implemented
- The model vendor’s marketing claims
- A promise to retrain whenever performance seems low
- Why should a PCCP define rollback or stopping criteria?
- To ensure every update is released
- To avoid collecting validation data
- To detect a failed change and prevent it from continuing in use
- To convert a 510(k) device into a PMA device
- Which statement about FDA guidance is accurate?
- It automatically replaces device regulations
- It applies only to devices cleared before 2020
- It guarantees approval for any plan that follows its headings
- It provides FDA recommendations; applicable statutes and regulations still govern